Jaguar Health (JAGX) Q1 2024 Annual Earnings
JAGX·Reported May 14, 2024·Before market open
Jaguar Health reported Q1 2024 revenue of $2.4M, beat analyst consensus of $2.3M by $51.0K. Diluted EPS came in at $-90.36, missed the $-38.73 consensus by $51.63.
Revenue
$2.4Mbeat by $51.0K
Consensus: $2.3MDiluted EPS
$-90.36missed by $51.63
Consensus: $-38.73
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Jaguar Health's Q1 2024 earnings report.
Jaguar Health (JAGX) reported Q1 2024 earnings on May 14, 2024 before market open.
Jaguar Health reported revenue of $2.4M and diluted EPS of $-90.36 for Q1 2024.
Revenue beat the consensus estimate of $2.3M by $51.0K. EPS missed the consensus estimate of $-38.73 by $51.63.
You can read the 10-K periodic report (0001558370-24-004439) directly on SEC EDGAR. The filing index links above go to sec.gov.